The Global NGS Sample Preparation Market Report is a comprehensive report by Emergen Research on the NGS Sample Preparation market, offering key insights on business strategies, current trends, and presenting qualitative and quantitative analysis of the NGS Sample Preparation market. This report offers in-depth research insights on key and significant aspects of the NGS Sample Preparation market, providing an in-depth analysis of key drivers, restraints, restraints, growth prospects, threats, and risks. The report also includes an in-depth analysis of the competitive landscape and regional scope of the NGS Sample Preparation market. Additionally, the report will be updated in line with changes in market dynamics and economic scenarios due to the COVID-19 pandemic.
In today's competitive marketplace, staying ahead of the curve is essential for businesses of all sizes. Understanding consumer behaviour, market trends, and emerging opportunities is crucial for making informed decisions and developing effective strategies. Emergen Research recognizes this need and has invested significant resources in developing a cutting-edge market research content library.
The newly launched NGS Sample Preparation market research content is meticulously crafted by industry experts, leveraging extensive data analysis, and a deep understanding of various markets. This rich collection includes in-depth reports, whitepapers, case studies, trend analyses, and industry insights covering a wide range of sectors, including but not limited to technology, healthcare, finance, consumer goods, and manufacturing.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/12
Competitive Landscape:
The latest study provides an insightful analysis of the broad competitive landscape of the global NGS Sample Preparation market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report.
Clinical Expansion of NGS and Workflow Automation Demands Are Driving Scalable, Standardized Sample Prep Solutions
The revenue growth in the NGS sample preparation market is being driven by the rapid clinical expansion of next-generation sequencing across oncology, infectious diseases, reproductive health, and inherited genetic disorders. As sequencing moves from research labs into regulated diagnostic settings, demand is accelerating for robust, repeatable, and automation-compatible sample preparation workflows that meet both clinical throughput and regulatory compliance requirements.
In 2024, over 45% of global sequencing volume was tied to clinical applications—up from less than 30% just five years prior—according to data from diagnostic labs and national genomics initiatives. This expansion is putting pressure on sample preparation systems like never before to provide low-input compatibility, sample integrity, and library conversion efficiency, particularly from challenging matrices such as plasma, FFPE tissue, and microbe samples.
Automation is increasingly emerging as a key value driver. Labs implementing high-throughput NGS pipelines are finding themselves more and more reliant on automated liquid handling, bead-based purification, and microfluidic library preparation systems to minimize manual error, shorten turnaround time, and allow 24/7 sample processing. Industry leaders like Thermo Fisher, PerkinElmer, and Agilent are introducing modular sample preparation systems that plug seamlessly into the installed base of sequencers and informatics environments.
Concurrently, multi-analyte panels—integrating DNA, RNA, and epigenetic markers—are becoming increasingly popular in applications including cancer profiling and rare disease diagnosis, further complicating sample preparation. Such a trend encourages demand for integrated reagent kits that enable parallel extraction, multi-omic normalization, and QC validation at speed.
The transition towards liquid biopsy and minimal residual disease (MRD) testing is also driving demand for ultra-sensitive prep technologies that can handle sub-nanogram input with retained variant fidelity. Large OEMs and startups are reacting with enzymatic fragmentation kits, low-bias ligation chemistries, and single-tube workflows intended to be easier to validate and minimize hands-on technician time.
As sequencing becomes integrated into clinical decision-making and evidence generation in real-world settings, NGS sample preparation is transforming from a manual, laboratory-specific operation into a standardized, industrialized process as a competitive driver for labs, diagnostics providers, and sequencing platform vendors.
Innovation & Trends
- End-to-End Automation of Sample Prep Workflows
Labs are adopting automated platforms that integrate extraction, fragmentation, library prep, and QC onto a single instrument. For instance, platforms such as Thermo Fisher's Ion Torrent Genexus and Agilent's Magnis are facilitating 24-hour sequencing with minimal hands-on activity.
- Enzymatic Fragmentation Replacing Mechanical Shearing
Enzymatic DNA shearing is displacing sonication and bead-based shearing, providing improved control, lower sample loss, and greater reproducibility, particularly for low-input and FFPE samples. NEB and Roche kits are driving clinical genomics adoption.
- Low-Input and Ultra-Low Volume Kits for Liquid Biopsy and MRD
Novel chemistries are enabling library construction from <1 ng input DNA, important for circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), and MRD therapies in oncology. Such kits minimize bias and maintain variant fidelity.
- Microfluidics and Cartridge-Based Prep Systems
New microfluidic platforms and disposable cartridges are streamlining NGS preparation for decentralized labs, with lower hands-on time, integrated contamination protection, and point-of-care genomics system compatibility.
- Multiplexed and Multi-omic Sample Prep Kits
Sample preparation is being redesigned for concurrent DNA/RNA profiling, epigenomics, and transcriptomics in a single process. These kits are picking up steam in cancer diagnostics and spatial genomics studies.
Emergen Research is Offering a full report (Grab a Copy Now) @ https://www.emergenresearch.com/industry-report/ngs-sample-preparation-market
Market Segmentation:
The report bifurcates the NGS Sample Preparation market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
The NGS sample preparation market is increasingly shaped by automation, platform-specific ecosystem development, and clinical validation. Leading companies are focusing on reducing turnaround times, minimizing input requirements, and expanding compatibility across a broad range of sequencing platforms and sample types. Strategic alliances, OEM bundling, and regional manufacturing are being leveraged to consolidate market share and localize delivery.
Major players like Illumina, Thermo Fisher Scientific, Qiagen, and Agilent are expanding their prep kit portfolios to support low-input, cell-free DNA, FFPE, and single-cell applications. Meanwhile, emerging players are innovating in ultra-fast enzymatic fragmentation, magnetic bead purification, and automation-ready reagent formulations to serve decentralized and resource-limited labs.
Companies are increasingly bundling prep kits with instruments and informatics pipelines, turning sample preparation into a value-added layer within end-to-end sequencing solutions. Competitive strategies also include acquisitions of niche prep technology firms, regulatory clearance of diagnostic-grade kits, and geographic expansion through distributor partnerships and local subsidiaries.
Some of the key companies in the global NGS Sample Preparation market include:
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- BGI
- Biomatters Ltd.
- Congenica Ltd
- Eurofins Scientific
- DNASTAR
- Hoffmann-La Roche Ltd
- Genomatix GmbH
- Thermo Fisher Scientific
- Foundation Medicine
Our goal at Emergen Research is to empower businesses with the knowledge and insights necessary to make informed decisions and thrive in today's dynamic business landscape. Our market research content is designed to equip professionals and organizations with comprehensive analyses, actionable recommendations, and a competitive edge to achieve their growth objectives.
The global NGS (Next-Generation Sequencing) Sample Preparation market size was USD 2.26 billion in 2024 and is projected to reach around USD 6.07 billion by 2034, growing at a CAGR of 10.4% during the forecast period. The revenue growth in this market is driven by the rapid expansion of sequencing applications in clinical diagnostics, precision oncology, pathogen surveillance, and agricultural genomics—placing mounting emphasis on reliable, high-throughput, and automation-ready sample prep workflows.
NGS sample preparation is a critical bottleneck and cost driver in sequencing pipelines, accounting for 25–40% of total workflow time and consumables cost. As demand rises for faster, cheaper, and clinically scalable NGS assays, there is growing focus on standardizing and automating library preparation, target enrichment, and nucleic acid QC processes.
Key players such as Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Roche are investing in sample prep platforms that enable higher throughput, improved consistency, and compatibility with low-input and degraded samples—especially in liquid biopsy, FFPE tissue, and metagenomics use cases.
Adoption is rising not only in high-complexity labs but also in clinical diagnostic settings, where providers are seeking end-to-end, kit-based solutions that reduce hands-on time, minimize error, and streamline regulatory validation. In parallel, microfluidics, bead-based automation, and enzymatic fragmentation technologies are replacing traditional labor-intensive steps, accelerating TAT and reducing sample loss.
The post-COVID surge in pathogen surveillance, coupled with national investments in genomic infrastructure (e.g., Genomics England, Genome India, NIH’s All of Us), is fueling decentralized NGS workflows across both public health and population genomics. As a result, sample preparation kits tailored for multiplexing, ultra-low input, and minimal manual handling are gaining commercial traction.
With sequencing costs continuing to fall and clinical applications scaling rapidly—from hereditary disease testing to cfDNA-based cancer screening—the sample preparation market is becoming a strategic growth lever for both platform companies and diagnostics developers.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/12
Target Audience of the Global NGS Sample Preparation Market Report:
- Key Market Players
- Investors
- Venture capitalists
- Small- and medium-sized and large enterprises
- Third-party knowledge providers
- Value-Added Resellers (VARs)
- Global market producers, distributors, traders, and suppliers
- Research organizations, consulting companies, and various alliances interested in this sector
- Government bodies, independent regulatory authorities, and policymakers
Key features and benefits of Emergen Research's market research content include:
- Comprehensive Analysis: Each piece of content is meticulously researched and provides a detailed analysis of market trends, competitive landscape, consumer behaviour, and emerging opportunities. Businesses can leverage this information to identify untapped markets, devise effective marketing strategies, and make data-driven decisions.
- Actionable Recommendations: The market research content provides practical insights and actionable recommendations to help businesses enhance their products, services, and overall customer experience. These recommendations are tailored to the specific needs and challenges of each industry, allowing companies to implement strategies that drive growth and profitability.
- Expert Insights: Emergen Research's team of industry experts and analysts contribute their in-depth knowledge and expertise to every piece of content. Their insights shed light on industry-specific challenges, best practices, and emerging trends, helping businesses stay ahead of the competition and seize new opportunities.
- Timely Updates: The market research content is regularly updated to reflect the latest market trends and dynamics. Subscribers will have access to the most up-to-date information, enabling them to adapt their strategies and stay relevant in today's rapidly evolving business environment.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com